Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2018 09:00 ET | Source: Centre for the Commercialization of Antibodies and Biologics

CCAB and Triumvira Immunologics Announce Triumvira’s License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates

AUSTIN, Texas and HAMILTON, Ontario and TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- The Centre for the Commercialization of Antibodies and Biologics (CCAB) and Triumvira Immunologics, Inc....